Exosomes for diabetes syndrome: ongoing applications and perspective
Authors:
- 7 March 2022
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 10 (9) , 2154-2171
Abstract
This review provides a comprehensive overview of the state-of-the-art progress on strategies that utilize exosomes, especially engineered exosomes, for the treatment of diabetes and its complications.Keywords
Funding Information
- Zhejiang Provincial Ten Thousand Plan for Young Top Talents (2018R52049)
This publication has 152 references indexed in Scilit:
- Therapeutic approaches to diabetic nephropathy—beyond the RASNature Reviews Nephrology, 2014
- Molecular Mechanisms in Autoimmune Type 1 Diabetes: a Critical ReviewClinical Reviews in Allergy & Immunology, 2014
- Diabetic peripheral neuropathy: Current perspective and future directionsPharmacological Research, 2014
- Molecular mechanisms of diabetic cardiomyopathyDiabetologia, 2014
- Diabetic neuropathy: clinical manifestations and current treatmentsThe Lancet Neurology, 2012
- Infusion of Mesenchymal Stem Cells Ameliorates Hyperglycemia in Type 2 Diabetic RatsDiabetes, 2012
- Wound healing and its impairment in the diabetic footThe Lancet, 2005
- Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine MechanismsCirculation Research, 2004
- Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes.Journal of Cell Biology, 1983
- Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptorCell, 1983